Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 25 Neoplasms 12 Stomach Neoplasms 10 Endometrial Neoplasms 10 Lung Neoplasms 9 Lymphatic Metastasis 7 Melanoma 6 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Rectal Neoplasms 5 Esophageal Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Vulvar Neoplasms 3 Sarcoma 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Skull Base Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Margins of Excision 2 Lymphedema 2 Hypoparathyroidism 2 Giant Cell Tumor of Bone 2

Interventions

Sorafenib 42 Bevacizumab 26 Oxaliplatin 21 Radiosurgery 19 Gemcitabine 17 Fluorouracil 15 Hepatectomy 13 lenvatinib 12 Radiofrequency Ablation 11 Nivolumab 11 Cisplatin 11 Radiotherapy 10 Doxorubicin 10 Capecitabine 10 durvalumab 9 Leucovorin 9 Blood Specimen Collection 9 atezolizumab 8 Liver Transplantation 8 Everolimus 7 Electroporation 7 pembrolizumab 6 camrelizumab 6 Sunitinib 6 Immunohistochemistry 6 Cryosurgery 6 Carboplatin 6 tremelimumab 5 sintilimab 5 apatinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Neoplasms × Indocyanine Green × Clear all

NCT05160740 2022-02-04

ICGMFITinPLC

Zhujiang Hospital

Phase NA Unknown

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡